Xynomic Pharmaceuticals Holdings Inc (XYNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 93 | 4,746 | 210 | 298 | N/A |
| Receivables | N/A | N/A | N/A | 25 | N/A |
| TOTAL | $423 | $5,024 | $300 | $323 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 290 | 281 | N/A | N/A | N/A |
| Investments And Advances | 0 | 0 | 62,208 | 0 | 0 |
| Intangibles | 1 | 2 | 0 | 0 | 0 |
| Other Non-Current Assets | 223 | 155 | 0 | 230 | 0 |
| TOTAL | $515 | $438 | $62,208 | $230 | $N/A |
| Total Assets | $938 | $5,462 | $62,508 | $553 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 5 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 0 | 0 | 79 | 0 | 0 |
| Other current liabilities | 23,096 | 17,641 | 2 | 230 | N/A |
| TOTAL | $23,501 | $17,646 | $81 | $530 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 7,911 | 57,428 | 0 | 0 |
| TOTAL | $N/A | $7,911 | $57,428 | $N/A | $N/A |
| Total Liabilities | $23,501 | $25,557 | $57,508 | $530 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,274 | N/A | N/A | N/A | N/A |
| Common Shares | 5 | 1 | 5,043 | 25 | N/A |
| Retained earnings | -59,427 | -34,323 | -43 | -2 | N/A |
| Other shareholders' equity | 39 | 59 | 0 | 0 | 0 |
| TOTAL | $-22,564 | $-20,095 | $5,000 | $23 | $N/A |
| Total Liabilities And Equity | $938 | $5,462 | $62,508 | $553 | $0 |